Investigators at the University of Pittsburgh have developed a novel biosensor utilizing metallized peptides which serve as conduits of electronic signals that bridge between a redox enzyme and a carbon-nanotube electrode. This invention optimizes contact and geometry between the redox enzyme and the carbon nanotube electrode array allowing for superior analyte sensing. This technology has been successful in detecting Prostate Specific Antigen (PSA). The electrochemical detection of PSA was carried out using cyclic voltammetry and exhibited low detection limit of 0.1 ng/mL.